节点文献

表达人肿瘤坏死因子受体Ⅱ-Fc的CHO-DG44细胞的培养温度优化研究

Optimization of the Culture Temperature of Recombinant CHO-DG44 Cells Expressing Tumor Necrosis Factor Receptor-Fc

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 雷云谢奎洪刚陈宝琼杨依丽谢秋玲熊盛

【Author】 LEI Yuna,d,XIE Kuic,HONG Ganga,d,CHEN Bao-qiongc,YANG Yi-lic,XIE Qiu-lingb,c,XIONG Shenga,c(Jinan University,a.Biomedical R&D Center;b.Guangdong Provincial Key Laboratory of Bioengineering Medicine;c.National Engineering Research Center of Genetic Medicine;d.College of Pharmacy,Guangzhou 510632,China)

【机构】 暨南大学生物医药研究开发基地暨南大学药学院暨南大学基因药物国家工程中心暨南大学广东省生物工程药物重点实验室

【摘要】 目的优化表达人肿瘤坏死因子受体Ⅱ-Fc(TNFR-Fc)融合蛋白的重组CHO-DG44细胞的培养温度,并考察该细胞株在最佳温度放大培养下纯化后的产物纯度及活性。方法采用批次培养方式,将重组中国仓鼠卵巢细胞培养于37℃、37℃转31℃、31℃3种不同的温度下,每日取样检测细胞密度、细胞活率、葡萄糖浓度、乳酸浓度、人肿瘤坏死因子受体Ⅱ-Fc融合蛋白浓度,并选择最佳的培养温度对重组中国仓鼠卵巢细胞进行放大(10、50、200 mL、2 L)培养,所得培养上清经Protein A亲和色谱柱纯化,并采用SDS-PAGE,SE-HPLC,WST-8对人肿瘤坏死因子受体Ⅱ-Fc融合蛋白进行相对分子质量,纯度和生物活性检测。结果研究发现,37℃转31℃的转温度培养条件可在保持高密度活细胞的同时维持细胞活率,延长培养周期,显著提高人肿瘤坏死因子受体Ⅱ-Fc融合蛋白产量,并且该转温度培养工艺可成功地应用于重组CHO细胞的规模放大培养中。纯化后的人肿瘤坏死因子受体Ⅱ-Fc融合蛋白相对分子质量约为150×103,纯度在93%以上,生物活性检测显示其可中和重组人肿瘤坏死因子α的细胞毒效应。结论相比单一的37℃培养条件,37℃转31℃的转温度培养工艺可明显提高重组CHO-DG44细胞的人肿瘤坏死因子受体Ⅱ-Fc融合蛋白表达量,且该工艺具有可放大性,这为该工艺的更大规模应用奠定了基础。

【Abstract】 OBJECTIVE To optimize the culture temperature of recombinant CHO-DG44 cells expressing tumor necrosis factor receptor-Fc fusion protein and to determine the bioactivity of expressed protein at the best culture temperature.METHODS Recombinant CHO cells were batchly cultured at three different temperatures(37 ℃,37 ℃ shifting to 31 ℃ and 31 ℃).Samples were daily tested for cell densities,viabilities,glucose concentration,lactic acid concentration and TNFR-Fc fusion protein concentration,then the best culture temperature was chosen to scale up the fermentation volume(10,50,200 mL,and 2 L).TNFR-Fc fusion protein was purified with Protein A affinity chromatography,determined for relative molecular mass,purity and neutralizing activity by SDS-PAGE,SE-HPLC and WST-8 separately.RESULTS The culture condition of 37 ℃ shifting to 31 ℃ resulted in the maximum viable cell density,high viability and long culture time of the cells as well as high TNFR-Fc protein productivity,and this culture procedure could be successfully applied to the scale-up of recombinant CHO cells.The purified fusion protein,with a relative molecular mass about 150 000,reached the purity of more than 93% and neutralized the cytotoxic effect of TNFα.CONCLUSION Compared to the traditional culture temperature of 37 ℃,the culture temperature of 37 ℃ shifting to 31 ℃ can obviously improve the TNFR-Fc fusion protein output by recombinant CHO-DG44 cells.And this technique can be applied to scale-up,which will lay a foundation of large scale industrial production.

【基金】 国家重大新药创制资助项目(2012ZX09103301-033,2012ZX09202301);暨南大学科研培育与创新基金杰出人才培育资助项目(1161-1206);抗体规模制备技术及肿瘤抗体药物的研究(2010U1-E00541)
  • 【文献出处】 中国药学杂志 ,Chinese Pharmaceutical Journal , 编辑部邮箱 ,2013年02期
  • 【分类号】R392.1
  • 【被引频次】1
  • 【下载频次】365
节点文献中: